 |
29 Products |  |
56 Diseases | | 29 Products |
|
154 Trials |  |
7457 News |  |
| «12...8283848586878889909192...9798» |
- Menopur (menotropin) / Ferring, Synarel (nafarelin) / Pfizer
New trial: Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization (clinicaltrials.gov) - Aug 12, 2016
P=N/A, N=60, Recruiting, Sponsor: New Hope Fertility Center
- | Firmagon (degarelix) / Astellas, Ferring, Yervoy (ipilimumab) / BMS
Enrollment closed, Enrollment change, Metastases: Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy (clinicaltrials.gov) - Aug 11, 2016
P2, N=16, Active, not recruiting, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Active, not recruiting | N=53 --> 16
- Euflexxa (hyaluronic acid) / Ferring
Trial completion, Enrollment change, Trial primary completion date, HEOR: Comparative Effectiveness of Hyaluronic Acid Injections for Management of Knee Osteoarthritis (clinicaltrials.gov) - Aug 11, 2016
P=N/A, N=13849, Completed, Sponsor: University of Arkansas
Recruiting --> Active, not recruiting | N=53 --> 16 Not yet recruiting --> Completed | N=20000 --> 13849 | Trial primary completion date: Dec 2016 --> Jul 2016
- | Cervidil (dinoprostone) / Ferring
New P2 trial: Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study (clinicaltrials.gov) - Aug 10, 2016
P2, N=250, Not yet recruiting, Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital
- | Cervidil (dinoprostone) / Ferring
New P2 trial: Early Amniotomy After Vaginal Prostaglandin E2 for Induction of Labor at Term: a Randomized Clinical Trial (clinicaltrials.gov) - Aug 5, 2016
P2, N=200, Not yet recruiting, Sponsor: Zeynep Kamil Maternity and Pediatric Research and Training Hospital
- | Euflexxa (hyaluronic acid) / Ferring
Enrollment closed, Trial primary completion date, MRI: To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection (clinicaltrials.gov) - Aug 2, 2016
P4, N=12, Active, not recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Completed | N=20000 --> 13849 | Trial primary completion date: Dec 2016 --> Jul 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Nov 2016
- Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - Jul 29, 2016
P4, N=150, Recruiting, Sponsor: Mansoura University
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Nov 2016 Trial primary completion date: Jun 2016 --> Sep 2016
- Menopur (menotropin) / Ferring
Trial initiation date, Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients (clinicaltrials.gov) - Jul 29, 2016
P4, N=150, Recruiting, Sponsor: Mansoura University
Trial primary completion date: Jun 2016 --> Sep 2016 Initiation date: May 2014 --> Oct 2014 | Trial primary completion date: Jun 2016 --> Sep 2016
- Erleada (apalutamide) / J&J, Firmagon (degarelix) / Astellas, Ferring
New P2 trial: A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy (clinicaltrials.gov) - Jul 29, 2016
P2, N=22, Not yet recruiting, Sponsor: University of Washington
- ||| Yonsa (abiraterone acetate) / Sun Pharma
Enrollment closed: NCI-2018-01856: Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer (clinicaltrials.gov) - Jul 28, 2016
P2, N=200, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Initiation date: May 2014 --> Oct 2014 | Trial primary completion date: Jun 2016 --> Sep 2016 Recruiting --> Active, not recruiting
- ||| Rebyota (fecal microbiota, live-jslm) / Ferring
Enrollment closed: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (clinicaltrials.gov) - Jul 27, 2016
P2, N=150, Active, not recruiting, Sponsor: Rebiotix Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date: Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=25, Recruiting, Sponsor: University of Washington
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2016 --> Nov 2016
- Cimzia (certolizumab pegol) / Astellas, UCB
Trial termination, Trial primary completion date: Cimzia Versus Mesalamine for Crohn's Recurrence (clinicaltrials.gov) - Jul 19, 2016
P4, N=10, Terminated, Sponsor: Milton S. Hershey Medical Center
Trial primary completion date: Jun 2016 --> Nov 2016 Active, not recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Jun 2016; Lack of accrual
- ||| Menopur (menotropin) / Ferring
New trial: A Study on Efficacy and Safety of Menopur (clinicaltrials.gov) - Jul 18, 2016
P=N/A, N=2002, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
- Cervidil (dinoprostone) / Ferring
New trial: Premature Rupture of Membranes With a Bishop Score<6: Comparison of Medical Induction/Expectant Management (clinicaltrials.gov) - Jul 7, 2016
P=N/A, N=300, Not yet recruiting, Sponsor: Rambam Health Care Campus
- Cervidil (dinoprostone) / Ferring
Enrollment open, Trial initiation date, Trial primary completion date: BALLODINO: Comparing the Efficiency of Cervical Ripening BALLoon (Cook) to the DINOprostone (Propess) for the Cervical Maturation in Case of Unfavorable Cervix (Bishop = 30 kg/m (clinicaltrials.gov) - Jul 1, 2016
P=N/A, N=240, Recruiting, Sponsor: Centre Hospitalier Departemental Vendee
Active, not recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Jun 2016; Lack of accrual Not yet recruiting --> Recruiting | Initiation date: Mar 2016 --> Jun 2016 | Trial primary completion date: Sep 2016 --> Dec 2017
- Trial primary completion date: Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF (clinicaltrials.gov) - Jun 28, 2016
P1/2, N=30, Enrolling by invitation, Sponsor: Center for Human Reproduction
Not yet recruiting --> Recruiting | Initiation date: Mar 2016 --> Jun 2016 | Trial primary completion date: Sep 2016 --> Dec 2017 Trial primary completion date: Jun 2016 --> Jun 2017
- Cervidil (dinoprostone) / Ferring
New trial: Comparing Cervical Foley Catheter, Dinoprostone and a Combination of the Two for Labor Induction (clinicaltrials.gov) - Jun 28, 2016
P=N/A, N=360, Not yet recruiting, Sponsor: Kaplan Medical Center
- ||| Bimzelx (bimekizumab) / UCB, Cimzia (certolizumab pegol) / Astellas, UCB
Clinical: Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis (clinicaltrials.gov) - Jun 20, 2016
P2, N=159, Active, not recruiting, Sponsor: UCB Celltech
Trial primary completion date: Jun 2016 --> Jun 2017 Recruiting --> Active, not recruiting | N=102 --> 159
- ||| Cimzia (certolizumab pegol) / Astellas, UCB
New P1 trial: Open-label, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy Subjects (clinicaltrials.gov) - Jun 20, 2016
P1, N=100, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
- || Firmagon (degarelix) / Astellas, Ferring
New P3 trial, Metastases: PEGASUS: Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer (clinicaltrials.gov) - Jun 16, 2016
P3, N=885, Not yet recruiting, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
- || Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: CIMAX: A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (clinicaltrials.gov) - Jun 10, 2016
P=N/A, N=678, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
Recruiting --> Active, not recruiting | N=102 --> 159 Trial primary completion date: Nov 2017 --> Mar 2018
- ||||| Cimzia (certolizumab pegol) / Astellas, UCB
Enrollment closed: RAPID-C OLE: An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044 (clinicaltrials.gov) - Jun 10, 2016
P3, N=347, Active, not recruiting, Sponsor: UCB Pharma SA
Trial primary completion date: Nov 2017 --> Mar 2018 Enrolling by invitation --> Active, not recruiting
- ||||||| Cimzia (certolizumab pegol) / Astellas, UCB
Trial completion: RAPID-C: A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis (clinicaltrials.gov) - Jun 10, 2016
P3, N=431, Completed, Sponsor: UCB Pharma SA, Belgium
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- Menopur (menotropin) / Ferring
Trial primary completion date: Mono-menotropins Versus rFSH Protocol on Embryo Quality (clinicaltrials.gov) - Jun 9, 2016
P=N/A, N=100, Recruiting, Sponsor: Main Line Fertility Center
Active, not recruiting --> Completed Trial primary completion date: Oct 2016 --> Apr 2017
- |||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Trial completion: Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer (clinicaltrials.gov) - Jun 5, 2016
P2, N=106, Completed, Sponsor: Millennium Pharmaceuticals, Inc.
Trial primary completion date: Oct 2016 --> Apr 2017 Active, not recruiting --> Completed
- Bravelle (urofollitropin) / Ferring
Enrollment change, Trial termination: Needle-Free Injections of Gonadotropins for Superovulation (clinicaltrials.gov) - Jun 1, 2016
P=N/A, N=2, Terminated, Sponsor: University of British Columbia
Active, not recruiting --> Completed N=60 --> 2 | Recruiting --> Terminated; This study is terminated due to an inability to recruit a sufficient number of participants.
- Actemra IV (tocilizumab) / Roche, JW Pharma
New trial: Re-Bone: Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers (clinicaltrials.gov) - May 20, 2016
P=N/A, N=66, Recruiting, Sponsor: University of Erlangen-N
- Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: PreCePRA: Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain (clinicaltrials.gov) - May 19, 2016
P3, N=156, Recruiting, Sponsor: University of Erlangen-N
N=60 --> 2 | Recruiting --> Terminated; This study is terminated due to an inability to recruit a sufficient number of participants. Trial primary completion date: Aug 2016 --> Dec 2018
- || Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: SECURE, the Cimzia (clinicaltrials.gov) - May 19, 2016
P=N/A, N=4000, Enrolling by invitation, Sponsor: UCB Pharma
Trial primary completion date: Aug 2016 --> Dec 2018 Trial primary completion date: Jan 2026 --> Jan 2027
- Menopur (menotropin) / Ferring
Trial primary completion date: HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients (clinicaltrials.gov) - May 18, 2016
P4, N=150, Recruiting, Sponsor: Mansoura University
Trial primary completion date: Jan 2026 --> Jan 2027 Trial primary completion date: Mar 2016 --> Jun 2016
- ||| Cimzia (certolizumab pegol) / Astellas, UCB
New trial: UCB Cimzia Pregnancy Follow-up Study (clinicaltrials.gov) - May 18, 2016
P=N/A, N=360, Not yet recruiting, Sponsor: UCB BIOSCIENCES, Inc.
- |||||||||| Adstiladrin (nadofaragene firadenovec-vncg) / Ferring
New P3 trial: rAd-IFN-CS-003: ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) (clinicaltrials.gov) - May 16, 2016
P3, N=135, Not yet recruiting, Sponsor: FKD Therapies Oy
- Bravelle (urofollitropin) / Ferring
Enrollment open, Trial primary completion date: Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia (clinicaltrials.gov) - May 16, 2016
P3, N=45, Recruiting, Sponsor: Instituto de Investigacion Sanitaria La Fe
Trial primary completion date: Mar 2016 --> Jun 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2016 --> Jun 2016
- Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: Study of Cimzia for the Treatment of Ulcerative Colitis (clinicaltrials.gov) - May 13, 2016
P2, N=25, Recruiting, Sponsor: Scott Lee
Not yet recruiting --> Recruiting | Trial primary completion date: Mar 2016 --> Jun 2016 Trial primary completion date: Dec 2013 --> Dec 2017
- Firmagon (degarelix) / Astellas, Ferring, Cetrotide (cetrorelix) / EMD Serono
Trial primary completion date: Dysregulation of FSH in Obesity: Functional and Statistical Analysis (clinicaltrials.gov) - May 12, 2016
P=N/A, N=68, Recruiting, Sponsor: University of Colorado, Denver
Trial primary completion date: Dec 2013 --> Dec 2017 Trial primary completion date: Jul 2016 --> Dec 2016
- || Cimzia (certolizumab pegol) / Astellas, UCB
Trial primary completion date: National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia (clinicaltrials.gov) - May 11, 2016
P=N/A, N=12500, Enrolling by invitation, Sponsor: UCB Pharma
Trial primary completion date: Jul 2016 --> Dec 2016 Trial primary completion date: Apr 2016 --> Aug 2016
- ||| Rebyota (fecal microbiota, live-jslm) / Ferring
Enrollment closed: PUNCHCD2: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (clinicaltrials.gov) - May 11, 2016
P2b, N=117, Active, not recruiting, Sponsor: Rebiotix Inc.
Trial primary completion date: Apr 2016 --> Aug 2016 Recruiting --> Active, not recruiting
- || Rebyota (fecal microbiota, live-jslm) / Ferring
Trial primary completion date: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (clinicaltrials.gov) - May 11, 2016
P2, N=150, Recruiting, Sponsor: Rebiotix Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Apr 2016 --> Aug 2016
- Pentasa (mesalamine) / Ferring, Takeda
New P3 trial: The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer (clinicaltrials.gov) - May 11, 2016
P3, N=40, Recruiting, Sponsor: Xijing Hospital of Digestive Diseases
- ||| merotocin (FE 202767) / Ferring
Trial initiation date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - May 10, 2016
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial primary completion date: Apr 2016 --> Aug 2016 Initiation date: Dec 2016 --> Mar 2017 | Trial primary completion date: Mar 2018 --> Jun 2018
- |||| Firmagon (degarelix) / Astellas, Ferring
Enrollment open, Metastases: A Trial to Evaluate Safety of Firmagon (clinicaltrials.gov) - May 5, 2016
P4, N=230, Recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Dec 2016 --> Mar 2017 | Trial primary completion date: Mar 2018 --> Jun 2018 Not yet recruiting --> Recruiting
- || Menopur (menotropin) / Ferring
Enrollment closed, Trial primary completion date: An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos (clinicaltrials.gov) - May 4, 2016
P=N/A, N=692, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Aug 2016
- || Bravelle (urofollitropin) / Ferring
Enrollment closed, Enrollment change, Trial primary completion date: Study of the Cleavage of the Egg in Relation to the Stimulation Treatment (clinicaltrials.gov) - May 4, 2016
P=N/A, N=272, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=600 --> 272 | Trial primary completion date: Nov 2016 --> Aug 2016
- Cervidil (dinoprostone) / Ferring
Phase classification: CYTOPRO: Comparison Between 25 (clinicaltrials.gov) - Apr 28, 2016
P2, N=1700, Completed, Sponsor: University Hospital, Toulouse
Recruiting --> Active, not recruiting | N=600 --> 272 | Trial primary completion date: Nov 2016 --> Aug 2016 Phase classification: P3 --> P2
- | Firmagon (degarelix) / Astellas, Ferring
Trial completion, Trial primary completion date: Degarelix in the Treatment of Endometriosis Recurrence (clinicaltrials.gov) - Apr 27, 2016
P3, N=100, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Phase classification: P3 --> P2 Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Mar 2016
- | Firmagon (degarelix) / Astellas, Ferring
Trial completion, Trial primary completion date: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Apr 27, 2016
P3, N=80, Completed, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Mar 2016 Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015
- || Firmagon (degarelix) / Astellas, Ferring
Enrollment change, Trial primary completion date: ProComD: Therapy Pathways in the Treatment of Hormone Na (clinicaltrials.gov) - Apr 22, 2016
P=N/A, N=500, Recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed | Trial primary completion date: Jun 2015 --> Dec 2015 N=1500 --> 500 | Trial primary completion date: Mar 2020 --> Dec 2020
- Firmagon (degarelix) / Astellas, Ferring
Enrollment closed, Trial primary completion date: Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer (clinicaltrials.gov) - Apr 19, 2016
P1, N=15, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
N=1500 --> 500 | Trial primary completion date: Mar 2020 --> Dec 2020 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Oct 2016
- Cervidil (dinoprostone) / Ferring
Trial primary completion date: Concurrent Membrane Sweeping With Dinoprostone Versus Dinoprostone in Labor Induction of Nulliparas at Term With an Unfavorable Cervix (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=192, Recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Oct 2016 Trial primary completion date: Jan 2016 --> Jul 2016